Memphasys

Memphasys (ASX:MEM)

Memphasys is an Australian biotechnology company, focussed on cell separation technology. Its most advanced program, the separation of sperm cells for human IVF, is currently in commercial development and has the potential to improve in vitro fertilisation clinical outcomes.